-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
December 08, 2014 - Staging
Staging involves determining the extent of disease and informs the choice of treatment. … improve detection of metastases (with
the potential to increase the stage and change the treatment choice … Choice of treatment (e.g., surgery, chemotherapy, radiation)
b. Timeliness of treatment
c. … Choice of treatment (KQ2 and KQ3)
6. … of test (or test strategy) may influence choice of
treatment, timeliness of treatment, harms due to
-
effectivehealthcare-admin.ahrq.gov/products/incident-user-design/research
August 01, 2019 - developing propensity scores to predict incident drug use is that it reminds investigators to model a choice … The choice to incorporate propensity scores into an analysis of comparative effectiveness is separate … from the choice to undertake an incident user design, but the two strategies work well together. … should disqualify them. 40 The incident user design helps investigators frame questions of treatment choice … Investigators using secondary data sources may not have a choice (e.g., claims data may not reflect the
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
May 01, 2012 - developing propensity scores to predict
incident drug use is that it reminds investigators to model a choice … The choice to incorporate propensity scores into an
analysis of comparative effectiveness is separate … from the choice to undertake an incident user
design, but the two strategies work well together. … should disqualify them.40 The incident user design helps
investigators frame questions of treatment choice … Investigators
using secondary data sources may not have a choice (e.g., claims data may not reflect
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/communicating_risk_international_king.ppt
January 01, 2005 - Evidence-based patient choice: a prostate cancer decision aid in plain language.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/gibbons.pdf
January 01, 2010 - CEO at User Interface Engineering (UIE)
• “The biggest misconception is
that companies
have a choice
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
January 01, 2010 - o What is the utility of CYP2C19 genetic testing for guiding treatment choice for
patients who require
-
effectivehealthcare-admin.ahrq.gov/health-topics/dietary-proteins
November 22, 2024 - An Empirical Evaluation of the Impact of Choice of Mean Difference Estimates
Research Protocol
-
effectivehealthcare-admin.ahrq.gov/health-topics/dietary-proteins?page=0
November 22, 2024 - An Empirical Evaluation of the Impact of Choice of Mean Difference Estimates
Research Protocol
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
January 01, 2011 - Slide 7
Conjoint analysis
Each participant receives N choice sets.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
September 01, 2014 - Treatment choice may be influenced by
availability, time commitment required for the family, child
-
effectivehealthcare-admin.ahrq.gov/health-topics/cholesterol
July 25, 2017 - An Empirical Evaluation of the Impact of Choice of Mean Difference Estimates
Systematic Review
-
effectivehealthcare-admin.ahrq.gov/health-topics/end-life-issues
May 04, 2017 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/health-topics/depression
June 26, 2024 - An Empirical Evaluation of the Impact of Choice of Mean Difference Estimates
Research Protocol
-
effectivehealthcare-admin.ahrq.gov/health-topics/dietary-fats
November 15, 2024 - An Empirical Evaluation of the Impact of Choice of Mean Difference Estimates
Research Protocol
-
effectivehealthcare-admin.ahrq.gov/health-topics/dietary-fats?page=0
November 15, 2024 - An Empirical Evaluation of the Impact of Choice of Mean Difference Estimates
Research Protocol
-
effectivehealthcare-admin.ahrq.gov/health-topics/depression?page=0
June 26, 2024 - An Empirical Evaluation of the Impact of Choice of Mean Difference Estimates
Research Protocol
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
November 19, 2009 - transferable across studies, and discuss miscellaneous issues that
range from statistical considerations to choice … and 2002 (coinciding with the transition between assays) has
been documented.50
Issues With the Choice … of Modeling Outcomes
The choice of the outcome that should be maximized—e.g., event-free survival,
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/bar-cohen_-eccs2012.pdf
January 01, 2012 - Bar-Cohen_ ECCS2012
Slide 1: Addressing
Tensions
When Social/Family Support and Evidence-‐
Based Care Collide
Annette Bar-‐Cohen, M.A., M.P.H., Discussant
Executive Director, Center for NBCC Advocacy Training
National Breast Cancer
Coalition,
Washington,
DC
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s58.pdf
October 01, 2007 - encounters; identification of rele-
vant clinical subgroups based on diagnostic information in
claims; choice … Choice of measures should be consistent with clinical information on desirable
medication use patterns … initia-
tion to end of observation period).29 Results using alternative
measures seem to vary mainly by choice … persis-
tence studies among New Jersey Medicaid beneficiaries.31
Clinical circumstances also inform choice
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
May 01, 2012 - It can be
understood in a straight-forward way if the indications for therapy (reasons for choice of … If some patient characteristics that lead to the
choice of one therapy over another are not measured … of prescribed treatment, the
concern is that a given variable may influence the choice of therapy and … In the case of the propensity score, the
outcome is treatment choice. … Generally the choice is between using the
entire population (treated and comparators) as the standard